HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CRIB, CRIB-II, birth weight or gestational age to assess mortality risk in very low birth weight infants?

AbstractAIM:
The mortality risk of very low birth weight (VLBW) (<1500 g) infants has been estimated by the Clinical Risk Index for Babies (CRIB). Superior discriminatory power has been claimed for the revised CRIB-II score based on birth weight, gestational age, sex, temperature and base excess (BE) at admission. This analysis compared the power of CRIB, CRIB-II, birth weight and gestational age to predict death prior to discharge.
METHODS:
Of 1485 consecutive VLBW infants admitted between January 1, 1991 and December 31, 2006, who survived for >or=12 h, CRIB and CRIB-II calculations were possible in 1358 infants (92%). Predictive power of variables was assessed by comparing areas under receiver operator characteristics curves (AUC).
RESULTS:
CRIB (AUC [95% confidence intervals] 0.82 [0.78-0.86]) performed significantly better than birth weight (0.74 [0.69-0.79]) or gestational age (0.71 [0.66-0.76]), while CRIB-II (0.69 [0.64-0.74]) was rather inferior to CRIB and did not differ significantly from birth weight or gestational age. No substantial changes were seen when substituting worst BE during the first 12 h of life for BE at admission when calculating CRIB-II.
CONCLUSIONS:
CRIB-II does not result in improved estimation of mortality risk in VLBW infants as compared to CRIB, birth weight or gestational age.
AuthorsChristoph Bührer, Boris Metze, Michael Obladen
JournalActa paediatrica (Oslo, Norway : 1992) (Acta Paediatr) Vol. 97 Issue 7 Pg. 899-903 (Jul 2008) ISSN: 0803-5253 [Print] Norway
PMID18435815 (Publication Type: Journal Article)
Topics
  • Acid-Base Equilibrium
  • Apgar Score
  • Area Under Curve
  • Birth Weight
  • Body Temperature
  • Female
  • Gestational Age
  • Humans
  • Infant Mortality
  • Infant, Newborn
  • Infant, Very Low Birth Weight
  • Male
  • ROC Curve
  • Risk Assessment
  • Sex Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: